Literature DB >> 3925146

Aldose reductase inhibitors: a potential new class of agents for the pharmacological control of certain diabetic complications.

P F Kador, J H Kinoshita, N E Sharpless.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3925146     DOI: 10.1021/jm00145a001

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  22 in total

Review 1.  Understanding the role of aldose reductase in ocular inflammation.

Authors:  U C S Yadav; S K Srivastava; K V Ramana
Journal:  Curr Mol Med       Date:  2010-08       Impact factor: 2.222

2.  Inhibition of aldose reductase by dihydroflavonols in Engelhardtia chrysolepis and effects on other enzymes.

Authors:  H Haraguchi; I Ohmi; H Masuda; Y Tamura; K Mizutani; O Tanaka; W H Chou
Journal:  Experientia       Date:  1996-06-15

3.  Purified rat lens aldose reductase. Polyol production in vitro and its inhibition by aldose reductase inhibitors.

Authors:  P F Kador; J H Kinoshita; D R Brittain; D J Mirrlees; C M Sennitt; D Stribling
Journal:  Biochem J       Date:  1986-11-15       Impact factor: 3.857

4.  In vitro expression of rat lens aldose reductase in Escherichia coli.

Authors:  S E Old; S Sato; P F Kador; D A Carper
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

Review 5.  Sorbitol, osmoregulation, and the complications of diabetes.

Authors:  M B Burg; P F Kador
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

6.  Binding of aldose reductase inhibitors: correlation of crystallographic and mass spectrometric studies.

Authors:  H Rogniaux; A Van Dorsselaer; P Barth; J F Biellmann; J Barbanton; M van Zandt; B Chevrier; E Howard; A Mitschler; N Potier; L Urzhumtseva; D Moras; A Podjarny
Journal:  J Am Soc Mass Spectrom       Date:  1999-07       Impact factor: 3.109

Review 7.  Epalrestat. A review of its pharmacology, and therapeutic potential in late-onset complications of diabetes mellitus.

Authors:  J W Steele; D Faulds; K L Goa
Journal:  Drugs Aging       Date:  1993 Nov-Dec       Impact factor: 3.923

8.  Design of an amide N-glycoside derivative of β-glucogallin: a stable, potent, and specific inhibitor of aldose reductase.

Authors:  Linfeng Li; Kun-Che Chang; Yaming Zhou; Biehuoy Shieh; Jessica Ponder; Adedoyin D Abraham; Hadi Ali; Anson Snow; J Mark Petrash; Daniel V LaBarbera
Journal:  J Med Chem       Date:  2013-12-23       Impact factor: 7.446

Review 9.  Oxidative stress. Biochemistry and human disease.

Authors:  A Bast; R J Goris
Journal:  Pharm Weekbl Sci       Date:  1989-12-15

10.  Effects of aldose reductase inhibition on the retina and health indices of streptozotocin-diabetic rats.

Authors:  W M Kozak; N A Marker; K K Elmer
Journal:  Doc Ophthalmol       Date:  1986       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.